131
HOSPICE ALLIANCE WORKSHOP: Hospice Compliance 1 PRESENTED BY: KATIE WEHRI, CHPC HEALTHCARE PROVIDER SOLUTIONS, INC. TARGETEDPROBEANDEDUCATE.COM [email protected]

HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HOSPICE ALLIANCE WORKSHOP: Hospice Compliance

1

P R E S E N T E D B Y :

K AT I E W E H R I , C H P C

H E A LT H C A R E P R OV I D E R S O LU T I O N S , I N C .

T A R G E T E D P R O B E A N D E D U C AT E . C O M

I N F O @H E A LT H C A R E P R OV I D E R S O LU T I O N S . C O M

Page 2: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Session 1: Hospice Regulatory and Policy Update

2

Page 3: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Payment Rates and Aggregate Cap

3

Page 4: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

FY2018 Hospice Payment Update PROPOSED

Code/Description FY2018 Rate Proposed FY2019 Rate

651/Routine Home Care days 1 - 60 $ 192.78 $196.25

651/Routine Home Care days 61+ $ 151.41 $154.21

Rates NOT adjusted for wage index, sequester or failure to meet HQRP requirements

4

Page 5: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

FY2018 Hospice Payment Update PROPOSED

Code/Description FY2018 Rate Proposed FY2019 Rate

652 -- Continuous Home Care (hourly rate

for SIA)

$976.42 ($40.68/hour) $998.77 ($41.62/hr.)

655 -- Inpatient Respite $172.78 $176.01

656 -- General Inpatient Care $743.55 $758.07

Rates are not adjusted for wage index, sequester or failure to meet HQRP requirements

5

Page 6: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice Cost Report Data Analysis

Median Cost Rate

Routine Home Care $125 $161.89

Continuous Home Care

(hourly)

$51 $39.37

Inpatient Respite $343 $167.45

General Inpatient Care $879 $720.11

6

Total Cost Per Day by Level of Care FY2016

Page 7: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice Cost Report Data AnalysisIs your agency correctly completing the hospice cost report?

“Level 1” edits◦ 66% of hospice cost reports would have been rejected

◦ “evident that hospices may not be providing thorough and representative cost data currently”

◦ “…substantial variation in the reported cost per day…”

7

Page 8: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Aggregate Cap

FY2018 cap amount: $ 28,404.99

FY2019 proposed cap amount: $ 29,205.44

8

Page 9: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Aggregate Cap Accounting Year Transition Time Frames

9

Streamlined Patient-by-patient (Proportional)

Patients Payments Patients Payments

2016 9/28/15-9/27/16 11/1/15-10/31/16 11/1/15-10/31/16 11/1/15-10/31/16

2017 9/28/16-9/30/17 11/1/16-9/30/17 11/1/16-9/30/17 11/1/16-9/30/17

2018 10/1/17-9/30/18 10/1/17-9/30/18 10/1/17-9/30/18 10/1/17-9/30/18

Page 10: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Payment RatesSequester

MACRA

CMS analysis of “new” cost report data◦ Rebasing

◦ Recalibrating

MedPAC◦ Recommendations of no increase

◦ Site of service

10

Page 11: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Electronic Processing NOE

CR10064 – Accepting Hospice Notices of Election via Electronic Data Interchange

Effective: January 1, 2017

Voluntary

Guidance for vendors to create interface

Overall intent: beneficiary status information to CWF faster

11

Page 12: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Electronic Processing NOE

Updates to Medicare Claims Processing Manual, Chapter 11

Reasons for exceptions to the 5-day NOE submission

Other sections added/updated◦ NOTR

◦ Change of provider/transfer

◦ Change of ownership

Corrections to admission date◦ Occurrence code 56

◦ Condition code D0

12

Page 13: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice and Managed Care

2014 MedPAC recommendation – bring hospice under MA bundle of services

Currently sets with Senate Finance Committee – Chronic Care Work Group

Same benefit bundle as FFS

Potential impact◦ Insufficient payment

◦ Selective contracting (no consumer choice)

◦ Copays for patients

13

Page 14: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Payment - Other Providers

Bipartisan Budget Act of 2018

Hospital transfer policy for early discharge to hospice care

Effective: October 1, 2018

Definition of “early”

Hospice now more closely aligned with post-acute providers

14

Page 15: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Trends in Hospice Utilization

15

Page 16: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

CMS Monitoring - Data

Length of stay

Live discharges

Skilled visits in last days of life

Non-hospice spending

16

Page 17: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice Utilization

$17.5 billion Medicare spending on hospice care

Expected to grow 8 percent annually

Central Budget Office (CBO)◦ all Medicare spending expected to grow 7% annually through 2028

◦ 5% due to cost

17

Page 18: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

FY2002 FY2007 FY2013 FY2015 FY2017

Lung CA Debility Debility Alzheimer’s Alzheimer’s

CHF Lung CA CHF CHF COPD

Debility CHF Lung CA Lung CA Heart Failure – unspec.

COPD COPD COPD COPD Senile Deg. of Brain

Alzheimer’s AFTT Alzheimer’s Senile Deg. of

Brain

Malignant Neoplasm Of Unsp

Part Of Unsp Bronchus Or

Lung

CVA/Stroke Alzheimer’s AFTT Parkinson’s Parkinson’s

Prostate CA Senile Dementia

(uncomp.)

Senile Dementia

(uncomp.)

Heart Disease ALZ – late onset

AFTT CVA/Stroke Heart Disease CVA/Stroke Atherosclerotic heart disease

native coronary w/o angina

pectoris

Breast CA (unspec.) Heart Disease CVA/Stroke Cerebral

Atherosclerosis

COPD – acute exacerbation

Senile Dementia

(uncomp.)

Prostate CA Dementia in Other Diseases

w/o Behaviors

Breast CA Cerebral atherosclerosis

18

Page 19: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Length of StayFY2015 FY2016 FY2017

Average Length of Stay 78.1 79.2 79.7 days

Average Lifetime Length

of Stay

96.1 96.2 96.2 days

Average Lifetime Length

of Stay (RHC at

admission)

114.02 113.5 days

ALOS Cancer (RHC) 63.7 days 63 days

ALOS

Chronic/Progressive

Neuro Disease (RHC)

165.3 days 177 days

Median Length of Stay Not Available 18 18 days

19

Page 20: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

20

Page 21: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Live DischargesOverall decreasing trend of 23.7% between FY2007 and FY2017

Approximately seventeen percent of all discharges were live discharges◦ revocations 44%

◦ discharges due to no longer terminally ill 45%

◦ transfers 11%

Median percentage of live discharges 17.3%◦ Range 6.9% to 47.6%

21

Page 22: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Skilled Visits in Last Days of LifeMonitoring especially since implementation of payment reforms and changes to the HQRP

Concern: lack of increase in visits

Hours of care in final days of life stable at 1.6 hours/day

Incremental improvement in FY2017 compared to FY2016◦ 42% of patients did not receive RN or MSW visit during last seven days

◦ 20% of patients did not receive RN or MSW visits on last day of life

22

Page 23: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Non- hospice SpendingMedicare non-hospice payments under Parts A, B and D during hospice election

Analysis suggests unbundling of items and services that perhaps could have been provided and covered under the Medicare hospice benefit

Decreases have occurred each year since reporting began◦ Overall decrease of 23% from FY2011 to FY2017

◦ Will continue to monitor

◦ Increase in Part D spending

23

Page 24: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Non-hospice Spending – Part DPA process has reduced payments in the four targeted categories

Analgesics Anti-nauseants

Anti-anxiety Laxatives

BUT INCREASE in Part D spending on maintenance drugs◦ Medications for heart disease, high blood pressure, asthma, diabetes

◦ Beta blockers, calcium channel blockers, corticosteroids and insulin

Are you properly assessing “relatedness”?

24

Page 25: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Session 2: Hospice Quality Reporting Program

25

Page 26: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HQRP UpdateNo new measures

Proposed changes to public reporting◦ Removal of routine reporting of 7 HIS measures

◦ Adding public use file (PUF) data to Hospice Compare

Data review and correction timeframes for HIS data

Extension of CAHPS Hospice Survey requirements

Procedures:◦ Announce QM ready for public reporting

◦ Public reporting timelines

26

Page 27: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Meaningful MeasuresImproving Patient Outcomes and Reducing Burden Through

Meaningful Measures

CMS initiative: Patients Over Paperwork

Aimed at identifying the highest priority areas for quality measurement and quality improvement in order to assess the core quality of care issues that are most vital to advancing our work to improve patient outcomes

27

Page 28: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Meaningful MeasuresAddress high-impact measure areas that safeguard public health

Patient -centered and meaningful to patients

Outcome-based where possible;

Fulfill each program’s statutory requirements

Minimize the level of burden for health care providers

Significant opportunity for improvement

Address measure needs for population based payment through alternative payment models; and

Align across programs and/or with other payers

28

Page 29: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Social Risk FactorsCMS asked for input for hospice last year – specific to CAHPS

Comments from FY2019 Hospice Proposed Rule◦ Stratified reporting

◦ Considering options to increase transparency of disparities

Dual eligibility most powerful predictor of poor health outcomes

NQF has extended the SES – Socio Economic Status trial

29

Page 30: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HQRP - MeasuresTwo new measures added FY2017◦ Hospice Visits When Death is Imminent (paired measure)

◦ Hospice and Palliative Care Composite Process Measure

National Quality Forum (NQF) status◦ Composite Process Measure approved

◦ CMS will submit the Paired Measure after data analyses

30

Page 31: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HQRP – Composite Process Measure

Hospice and Palliative Care Composite Process Measure

Data on seven care processes will be captured

Calculates the percentage of patients who received all care processes at

admission

Individual components assessed separately for each patient and

aggregated into one score for each hospice

Serves to ensure all hospice patients receive a comprehensive assessment

for both physical and psychosocial needs at admission

31

Page 32: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HQRP MeasuresProposed:

Add Composite Process Measure to Hospice Compare

Eliminate routine reporting of 7 HIS measures from Hospice Compare◦ NQF #1641 – Treatment Preferences ◦ Modified NQF #1647 – Beliefs/Values Addressed ◦ NQF #1634 & NQF #1637 – Pain Screening and Pain Assessment ◦ NQF #1639 & NQF #1638 – Dyspnea Screening and Dyspnea Treatment◦ NQF #1617 – Patients Treated with an Opioid who are Given a Bowel

Regimen

32

Page 33: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HQRP - MeasuresPrevious CMS Comments: Measure concepts under consideration

Access to levels of hospice care

Potentially Avoidable Hospice Care TransitionsLive discharges

- Shortly followed by death or acute stay

- Comparison of performance to peers

- Would be risk adjusted

Claims-based measures

33

Page 34: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HQRP – MeasuresTransitions From Hospice Care, Followed by Death or Acute Care

Live Discharges followed by:

- Death within 30 days

- Acute care within 7 days

-hospitalization/ER visit/observation

CMS requested feedback recently

34

Page 35: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice CompareProposed:

Add Composite Process Measure to Hospice Compare Fall 2019

Add Hospice Utilization and Payment Public Use File (PUF) data

Anticipate:

Adding Hospice Visits When Death is Imminent measure later in FY2019

35

Page 36: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice ComparePUF Data

User-friendly format

Section separate from the HIS and CAHPS Hospice Survey results

Align with other providers

Examples of PUF data• Percent of days a hospice provided routine home care (RHC) to patients, averaged over

multiple years

• Percent of days a hospice provided routine home care (RHC) to patients, averaged over multiple years

• Site of service (long term care or non-skilled nursing facility, skilled nursing facility, inpatient hospital) with a notation of yes, based on whether the hospice serves patients in that facility type

36

Page 37: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice CompareProposed:

Eliminate routine reporting of 7 HIS measures from Hospice Compare- NQF #1641 – Treatment Preferences

- Modified NQF #1647 – Beliefs/Values Addressed

- NQF #1634 & NQF #1637 – Pain Screening and Pain Assessment

- NQF #1639 & NQF #1638 – Dyspnea Screening and Dyspnea Treatment

- NQF #1617 – Patients Treated with an Opioid who are Given a Bowel Regimen

37

Page 38: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

APU – Current Measures

38

Page 39: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice Compare

Proposed:

Timeframe to review and correct data to be publicly reported HIS data

Align with PAC

Approximately 4.5 months after the end of each CY quarter

- 15th of the month - 11:59:59 PST

- January 1, 2019

39

Page 40: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice Compare

40

Page 41: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice Compare

Proposed:

Announce future intent to report a quality measure on Hospice Compare through sub-regulatory means

41

Page 42: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Measure Removal Factors7 finalized FY2018 Final Rule

Proposed for FY2019:

The costs associated with a measure outweighs the benefit of its continued use in the program

42

Page 43: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Measure Removal FactorsMeasure performance among hospices was so high and unvarying that meaningful distinction in improvements in performance could no longer be made.

Performance or improvement on a measure did not result in better patient outcomes.

A measure did not align with current clinical guidelines or practice.

A more broadly applicable measure (across settings, populations, or conditions) for the particular topic was unavailable.

A measure that was more proximal in time to desired patient outcomes for the particular topic was not available.

A measure that was more strongly associated with desired patient outcomes for the particular topic was not available.

Collection or public reporting of a measure led to negative unintended consequences

43

Page 44: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

CAHPS Hospice SurveyProposed:

Extend participation requirements to all future years

Extend public reporting policies to future years

Continue policy for volume based exemption to future years

Continue policy for newness exemption to future years

44

Page 45: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Social Risk Factors

CMS asked for input for hospice last year – specific to CAHPS

Comments from FY2019 Hospice Proposed Rule

• Stratified reporting

• Considering options to increase transparency of disparities

• Dual eligibility most powerful predictor of poor health outcomes

• NQF has extended the SES – Socio Economic Status trial

45

Page 46: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Social Risk Factors

Previous CMS Comments:

Some concerns over selective admissions

Future rulemaking

CMS considering publishing adjusted data and confidentially providing hospices with unadjusted data

46

Page 47: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Comprehensive Patient Assessment Instrument

HEART – Hospice Evaluation & Assessment Reporting Tool

CMS currently in early stages of development of comprehensive patient assessment instrument tool

Tool would serve two primary objectives

• provide the quality data necessary for HQRP requirements and the current function of the HIS; and

• provide additional clinical data that could inform future payment refinements

47

Page 48: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HEARTAllows more detailed clinical information collection

- Symptom burden

- Functional status

- Patient, family, and caregiver preferences

Information for use in development of future quality measures

Data used for both quality and payment purposes

48

Page 49: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HEART

• Would replace HIS

• Would NOT replace current assessment requirements

• Would be completed at

◦ Admission

◦ Discharge

◦ Intervals in between, possibly

49

Page 50: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HQRP & Payment

HEART ◦Value based purchasing

◦Case-mix based payment system

50

Page 51: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

HQRP – Public ReportingFive Star Rating

Will be part of the HQRP

Historically implemented approximately one year after Compare site

Hospice may take longer

51

Page 52: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Requests for Information, Physician Assistants as Attending Physicians

52

Page 53: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Request for InformationFY2018 Proposed Rule: National conversation on improvements that

reduce unnecessary burdens

lower costs

improve quality

One particular suggestion warrants revision to current policy – removal of detailed drug data on hospice claims effective October 1, 2018

option to report detailed information or aggregate data

option to report detailed DME information or aggregate data

Change Request (CR) 10573 released April 27, 2018

53

Page 54: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Request for InformationInteroperability

◦ Possible Establishment of CMS Patient Health and Safety Requirements for Hospitals and Other Medicare-Participating Providers and Suppliers for Electronic Transfer of Health Information

◦ Conditions of participation/Conditions for coverage

◦ Patient and provider access

54

Page 55: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Physician Assistants Recognized as Attending PhysiciansPAs recognized as attending physicians

January 1, 2019

PAs Cannot:◦ Certify or recertify a hospice patient

◦ Conduct F2F encounters

◦ Fulfill the physician role on the Interdisciplinary Group (IDG)

PA services reasonable and necessary for beneficiaries who elect the PA as their attending will be paid by Medicare at 85% of the physician fee schedule

55

Page 56: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Oversight

56

Page 57: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

OIGDuplicate Drug Claims for Hospice Beneficiaries

Medicare Payments for Unallowable Overlapping Hospice Claims and Part B Claims

Trends in Hospice Deficiencies and Complaints

Hospice Home Care — Frequency of Nurse On-Site Visits to Assess Quality of Care and Services

Review of Hospices’ Compliance with Medicare Requirements

Medicare Payments for Chronic Care Management

Medicare Hospice Benefit Vulnerabilities and Recommendations for Improvement: A Portfolio

57

Page 58: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

MedPACNo payment update◦ Projected 2018 aggregate Medicare hospice margin is 8.7%

◦ Adequate access to capital – number of hospices increasing

Greater program integrity focus:◦ Hospices over the aggregate cap◦ Long stays and high live-discharge rates

◦ Medical review focused on hospices that have many long stay patients◦ All sites, and

◦ Assisted Living Facilities (ALF)

◦ Possible: providers that receive a high share of their payments for hospice patients before the last year of life

58

Page 59: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Regulation/Policy

59

Page 60: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Medicare Part D PrescribersRequires active and valid physician or eligible practitioner NPI on the claim

All prescribers must be enrolled in PECOS/have valid opt out by January 1, 2019◦ Tiered implementation

https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/MedicareProviderSupEnroll/Prescriber-Enrollment-Information.html

60

Page 61: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Inpatient Units – Life Safety CodeS&C 17-38 LSC

Effective: January 1, 2018

Annual inspection and testing in accordance with the 2010 NFPA 80 is required for all fire door assemblies

Non-rated doors, including corridor doors to patient care rooms and smoke barrier doors, are not subject to the annual inspection and testing requirements of either NFPA 80 or NFPA 105.

But, non-rated doors should be routinely inspected as part of the facility maintenance program as all required life safety features and systems must be maintained in proper working order

61

Page 62: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Medicare Beneficiary Identifier

In lieu of social security number/identifier

No later than April 1, 2019

62

Page 63: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Bipartisan Budget Act of 2018Physician Assistants allowed as attending physicians for hospice patients

63

Page 64: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Opioids/Medications

DEA Disposal Act ◦ Effective October 9, 2014

◦Many states responding with state-specific legislation

Nursing home requirements – F757 Unnecessary Medications◦ PRN Anti-psychotics

◦ PRN Psychotropics

64

Page 65: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IMPACT ActThe Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014 ◦ Requires home health agencies and other health care providers to report

standardized patient assessment data in an effort to provide better and more affordable care

◦ Reporting of standardized patient assessment data with regard to quality measures, resource use, and other measures◦ Data elements are standardized and interoperable

◦ Cross-setting quality comparisons

65

Page 66: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

66

Page 67: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

67

Page 68: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Session 3: Live Discharges, Long/Short Lengths of Stay

68

Page 69: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Live DischargesOverall decreasing trend of 23.7% between FY2007 and FY2017

Approximately seventeen percent of all discharges were live discharges◦ revocations 44%

◦ discharges due to no longer terminally ill 45%

◦ transfers 11%

Median percentage of live discharges 17.3%◦ Range 6.9% to 47.6%

69

Page 70: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Live DischargesOverall decreasing trend of 22.8% between FY2007 and FY2016

Timing

◦ 26% within 30 days of start of hospice care

◦ 13% between 31-60 days

◦ 14% between 61-90

◦ 19% between 91-180

◦ 28% after 180 days

Seventeen percent of all discharges were live discharges

◦ revocations 38%

◦ discharges due to no longer terminally ill 51%

◦ transfers 11%

70

Page 71: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Types of Live Discharges◦Transfer (NOT a discharge)

◦Revocation

◦No longer terminally ill

◦Move out of service

71

Page 72: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Live Discharge DifferencesWHO initiates the discharge◦ Patient can revoke at any time for any reason

◦ Hospices can only discharge a patient for certain reasons◦ Moves out of service area

◦ No longer terminally ill

◦ Discharge for cause

Revocations must be in writing

Revocations can not be backdated

72

Page 73: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Length of StayLong length of stay: 180, 240, 365, 730 days

Continuing concerns

Targeted probe and educate

Short length of stay: 2, 7 days

10th and 25th percentile respectively

Unique challenges with expenses and quality of care

“high” and “low” routine home care rate has helped

73

Page 74: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

MonitoringKnow which diagnoses are prone to longer lengths of stay

Know YOUR diagnoses

Know YOUR LOS – median, average, CURRENT patients

Know YOUR live discharge rate

74

Page 75: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Hospice – When?

Prognosis of 6 months or less if the illness follows its normal course

75

Page 76: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Eligibility - Common Problems

Terminal condition not supported◦ Lack of consistent, objective data

◦ Lack of comparison

◦ Karnofsky/PPS not supported by other documentation

◦ Incorrect use of scales/screening tools◦ FAST

◦ PPS, etc.

Page 77: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Eligibility - Common ProblemsLCD not supported

Chronic v. terminal condition

Assessment is not thorough/not thoroughly documented

Not utilizing IDG documentation

Not referencing the plan of care

Page 78: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Eligibility

Must a patient decline in order to remain eligible?

Does decline equal eligibility?

Compare patient over time

Page 79: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Eligibility

Ongoing Eligibility

◦ every update to the comp assessment

◦ IDG summaries

◦Visit Notes

Page 80: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

ToolsLCDs◦ Guidelines

◦ Validated?

Non-LCD Tools◦ H&P

◦ Patient examination – comprehensive assessment

◦ ADLs, BMI, Weight, MAC, etc.

◦ Diagnosis and expected disease progression

◦ Physician judgement

80

Page 81: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Tools

Non-LCD◦PPS/KPS, FAST, NYHA Class, Wong-Baker, etc.

◦PaP – Palliative Prognostic Score

◦ADEPT

◦MELD

◦Others….

81

Page 82: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

82

Page 83: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Starts At AdmissionBaseline

◦ Upon which all further comparisons are made

Why hospice now?

Physician synthesizes information/data available

Still needs a comparison over time

Why is the patient not considered chronic/custodial care

All comorbidities

OBJECTIVE MEASURES

83

Page 84: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

RecertificationYes, address LCDs, but…

Is it the patient or is it the documentation

Comparison◦ Baseline

◦ Start of benefit period

◦ Last update to the comprehensive assessment

Answer◦ Why is the patient not chronic/custodial care

84

Page 85: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

RecertificationLooking for significant changes◦ Charts/graphs helpful

ADLs◦ Time to complete

◦ Severity of dependence

Responsiveness

Strength

Sleeping

Lucidity

I/O

85

Page 86: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Discharge?Is it the patient or is it the documentation

The patient is eligible TODAY

Do not wait until end of benefit period!

86

Page 87: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

87

Page 88: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Session 4: The IDG Meeting & Hot Topics in Hospice

88

Page 89: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

The IDG Meeting

624 HOURS

$30,000

Page 90: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDGComposed of individuals who work together to assess and meet the physical, medical, psychosocial, emotional and spiritual needs of hospice patients and families facing terminal illness and bereavement.

The individuals must include◦ Physician

◦ RN

◦ Social Worker

◦ Pastoral or other counselor

Page 91: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDG ResponsibilitiesTimely completion of the comprehensive assessment, in consultation with the patient’s attending physician (if any)

Update of the comprehensive assessment, in consultation with the patient’s attending physician (if any), as frequently as the patient’s condition requires but no less than every 15 days

Prepare, in consultation with the patient’s attending physician (if any), a written plan of care (must also include the patient/representative, and primary caregiver, in accordance with the patient’s needs, if any of them so desire)

Must provide the care and services offered by the hospice AND,

The group, in its entirety, must supervise the care and services

Page 92: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDG Responsibilities, contd.Review, revise, and document the individualized plan as frequently as the patient’s condition requires, but no less frequently than every 15 calendar days.

Document patient’s/representative’s level of understanding, involvement and agreement with the plan of care

Must maintain responsibility for directing, coordinating, and supervising the care and services provided.

Order HHA services and prepare instructions for homemaker services

Person coordinating homemaker services must be a member of the IDG

Confers with an individual with education and training in drug management as defined in hospice policies and procedures and State law, who is an employee of or under contract with the hospice to ensure that drugs and biologicals meet each patient’s needs

Must determine the ability of the patient and/or family to safely self-administer drugs or biologicalsto the patient in his or her home.

Page 93: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDG Responsibilities, Contd.

Coordination of services◦Develop and maintain a system of communication and

integration…to ensure◦ The IDG maintains responsibility for directing, coordinating, and supervising the care and

services provided

◦ Ongoing sharing of information between all disciplines providing care and services in all settings (directly or under arrangement)

◦ Ongoing sharing of information with non-hospice providers furnishing unrelated care

◦ That care and services provided are in accordance with the plan of care

◦ That care provided is based on all assessments of patient and family needs

Page 94: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

What Can Be Accomplished During The IDG Meeting?Update of the comprehensive assessment

Review/revision of the plan of care

Directing, coordinating, and supervising care and services provided

Coordinating services (system of communication and integration)

Page 95: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Update of the Comprehensive AssessmentALL components of the comprehensive assessment must be addressed

Severity of symptoms and progress toward desired outcomes

Clearly identified

Do this as often as the patient’s condition requires but at least every 15 days

REMINDER: Must be done by the IDG in consultation with the patient’s attending physician (if any)

Page 96: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Review/Revision to the Plan of CareDirect link between needs identified in the comprehensive assessment and the plan of care

Problem, intervention, goal

Measurable outcomes◦ Note patient’s progress toward goal

◦ Are the interventions effective?

Page 97: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Directing, Coordinating, and Supervising CareEnsure care provided is based on all assessments (don’t forget bereavement)

Ongoing sharing of information ◦ Between all disciplines

◦ All settings

Page 98: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDG MeetingsIDG responsibilities - summary◦ Comprehensive assessment and plan of care development

◦ Update to the comprehensive assessment

◦ Review (and revision) of the plan of care

◦ Directing, coordinating and supervising care and services provided

◦ Ongoing sharing of information between all disciplines providing care and services in all settings

Page 99: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDG MeetingsWhat can be accomplished?

Update of the comprehensive assessment

Review/revision of the plan of care

Directing, coordinating, and supervising care and services provided

Coordinating services (system of communication and integration)

Page 100: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

What Spectators See

Unprepared participants/The RN case manager who can’t give a report

because she didn’t make the last visit

Absent participants and no coverage

No mention of plan of care, interventions, goals!!!!!!

A report of the nurses’ last visit

No reference to the LCDs during recertification decisions

Tangents, tangents, tangents!!!

Page 101: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Culture of the IDG◦An interdisciplinary culture must be a culture by design – the IDG

must be designed – it does not happen naturally

◦ It requires commitment from team members – they must be prepared

Page 102: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

How to fix it??Develop an agenda for the meeting

Assign individuals to the following roles:◦ Facilitator

◦ Timekeeper

◦ Recorder

◦ Come prepared to the meeting

◦ Make sure each staff person has a DNR

DO NOT RAMBLE!!!!

Page 103: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDG AgendaDeaths

Admissions

Recerts

Review of existing patients

Page 104: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Presentation of…deathsPatient’s name, place and date of death

BRIEF description (peacefully at home, family present, daughter made it in time to say good-bye, etc.)

Any bereavement risks

Assign someone to bereavement

Bereavement plan of care

Page 105: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Presentation of…admissionsCall facility

Patient’s name, age, sex, diagnosis, location, attending physician

BRIEF history of terminal illness and comorbidities

Review of patient’s eligibility – using LCD guidelines

Review of the comprehensive assessment and plan of care that was developed on admission

◦ Problems (are there too many?)

◦ Goals (palliative care outcomes)

◦ Interventions

◦ Scope and frequency

◦ Any necessary revisions?

◦ If revisions, the recorder needs to give a summary of the revisions before moving on to the next person

Page 106: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Presentation of…recertificationsCall facility

Patient’s name, age, sex, diagnosis, location and attending physician

LCD guidelines and how patient meets them (e.g. “Patient continues to be eligible as evidenced by…” or “no longer eligible as evidenced by…”)

Any updates to the comprehensive assessment

Review of the plan of care

Page 107: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Presentation of…existing patientsCall facility

Patient’s name, age, sex, diagnosis, location and attending physician

Review of the update to the comprehensive assessment and the plan of care

◦ State the problem on the plan of care (or any new problems that need to be added)

◦ Was the problem resolved? If so, REMOVE it

◦ If symptoms/issues being controlled currently and nothing further is needed, then state just that –NOTHING ELSE

◦ Were there any changes to the interventions (or any new interventions that need to be added)

◦ Be sure to include spiritual and social work in this process

◦ Continued eligibility

◦ Summary if any changes needed

Page 108: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDT “Do’s” and “Don’ts”DO have access to the Plan of Care and updates to the comprehensive assessment

DO come prepared (know the problems, goals, and interventions for each of your patients)

DO hold each other accountable to staying on script

DO provide food

Page 109: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

IDT “Do’s” and “Don’ts”DON’T come to IDG unprepared

DON’T miss IDG without preparing someone to cover for you

DON’T save all of your communication for the IDG meeting

DON’T share the story of your last visit

DON’T hesitate to hold others accountable

Page 110: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

110

Page 111: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Top Ten Hospice Deficiencies 2017ALL

1. Plan of Care – L543

2. Timeframe for completion of assessment – L523

3. Content of the comprehensive assessment – L530

4. Supervision of Hospice Aides – L629

5. Content of plan of care – L545

AO ONLY

1. Coordination of Care – L555

2. Plan of Care – L543

3. Rights of the Patient – L512

4. IDG, Care Planning, Coordination of Services – L536

5. Clinical Record – L671

111

Page 112: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

L-tags

112

https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap_m_hospice.pdf

Page 113: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

113

Page 114: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

All services provided must follow an:

Individualized

Written, plan of care, that is

Established by the Hospice IDG in consultation with

o the attending physician (if any)

o Patient or representative

o And primary caregiver

In accordance with the patient’s needs if any of them so desire

114

Plan of Care – L543

Page 115: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Plan of Care – L543Survey finding examples:

Not delivering care according to the plan of care

Not having orders for items on the plan of care

Not including the required individuals

Not incorporating updated comprehensive assessment information into the plan of care/not individualizing this information

115

Page 116: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Plan of Care – L543Interdisciplinary group

◦ Physician

◦ RN

◦ Social worker

◦ Chaplain, or other counselor

In consultation with attending physician, if any

116

Page 117: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

QUALIFIED AIDE

CNA

Competency program

Training and competency program

117

Page 118: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Every Patient, Every ClaimCertification of terminal illness (CTI)

Valid election statement

Notice of election – timely submission and acceptance

Plan of care

118

Page 119: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Certification of Terminal Illness (CTI)Purpose is for physician(s) to certify/recertify that a patient is terminally ill

Eligibility component

Technical component

◦ Timing

◦ Form components

119

Page 120: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

CTI – ConcernsOIG – “Hospices Should Improve Their Election Statements and Certifications of Terminal Illness”

Current requirement is that medical director must consider at least

the following

◦ Diagnosis of the terminal condition

◦ Other health conditions, related or unrelated

◦ Current clinically relevant information supporting all diagnoses

120

Page 121: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Certification of Terminal Illness (CTI)Purpose is for physician(s) to certify/recertify that a patient is terminally ill

Eligibility component

Technical component

◦ Timing

◦ Form components

121

Page 122: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

CTI – ConcernsOIG – “Hospices Should Improve Their Election Statements and Certifications of Terminal Illness”

Current requirement is that medical director must consider at least

the following

◦ Diagnosis of the terminal condition

◦ Other health conditions, related or unrelated

◦ Current clinically relevant information supporting all diagnoses

122

Page 123: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

CTI – F2F EncounterSome Common Problems

• Illegible signatures/dates

• Unsigned/undated documents

• Initial certifications aren’t obtained from both attending physician (if one) and hospice physician

• Recertification not obtained from hospice physician

• Required components not placed in proper location/not titled properly

123

Page 124: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

CTI – F2F EncounterSome Common Problems

• Not utilizing the proper professional (e.g. NP is not employed, etc.)

• CTI completed prior to the 15 days before the start of the benefit period OR more than two days after the start of the benefit period

124

Page 125: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Election StatementPurpose is for the patient to make the election of hospice care and to understand this election

◦ Waiver of traditional Medicare benefits

◦ Choice of attending physician

◦ Effective date

Technical components

125

Page 126: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Election Statement – ConcernsOIG – “Hospices Should Improve Their Election Statements and Certifications of Terminal Illness”

◦ Complete and accurate information

Missing required information

126

Page 127: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Election Statement – Common ProblemsDoes not contain:

◦ Name of the hospice

◦ Waiver

◦ Attending physician

◦ Acknowledgement of palliative nature of hospice care

◦ Signature of patient or legal representative

127

Page 128: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Election Statement – Common ProblemsDoes not contain:

◦ Name of the hospice

◦ Waiver

◦ Attending physician

◦ Acknowledgement of palliative nature of hospice care

◦ Signature of patient or legal representative

128

Page 129: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Resourceswww.ngsmedicare.com

www.cgsmedicare.com

www.palmettogba.com

Technical requirements of the CTI/F2F and Election

◦ Medicare Benefit Policy Manual, Chapter 9, Section 20

◦ http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/bp102c09.pdf

129

Page 130: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

130

Page 131: HOSPICE ALLIANCE WORKSHOP: Hospice Compliance...Breast CA Cerebral atherosclerosis 18. Length of Stay FY2015 FY2016 FY2017 Average Length of Stay 78.1 79.2 79.7 days Average Lifetime

Healthcare Provider Solutions, Inc.

810 Royal Parkway, Suite 200

Nashville, TN 37214

615.399.7499 - 615.399.7790

[email protected]

www.healthcareprovidersolutions.com